News – Page 954 – Endpoints News

Biohaven is betting hundreds of millions it can hustle ahead of rivals in a blockbuster race. A quick M&A deal could ...

7 years ago

Aerpio shares tumble as lead eye drug trips up in mid-stage diabetic retinopathy study

7 years ago

Oncology dominates a 'Cambrian explosion' in China's drug pipeline as McKinsey guru bets on a burst of innovation

7 years ago

Little Dermira’s shares zoom up on promising PhIIb atopic dermatitis data — but the road ahead is ultra risky and ...

7 years ago

Arch-backed biotech hauls in a fast B round as its reborn anti-psychotic zooms to a PhII finish line

7 years ago

Months away from completing a key sickle cell trial, upstart Imara scores $63M in round co-led by Arix, Orbimed

7 years ago

Gilead CEO Milligan capped a rocky year — and his career — with the new #1 compensation package in the big ...

7 years ago

AstraZeneca vet Jennifer Butler takes charge of Innate Pharma's US biz; C4 raids NIBR

7 years ago

Desperately seeking a turnaround, beleaguered veteran fund manager Woodford hits out at critics, fake news

7 years ago

Genfit readies its $120M IPO; Karyopharm shares boosted after an FDA delay for selinexor

7 years ago

Scott Gottlieb to biopharma: You wanted us to help modernize R&D, now go out and do it

7 years ago

Spectrum yanks marketing application for Neulasta rival after FDA demands more data

7 years ago

The world's top 10 blockbusters — and what they tell us about R&D trends

7 years ago

South Korean investigators raid stock exchange in another Samsung BioLogics IPO probe — report

7 years ago

Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid ...

7 years ago

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a ...

7 years ago

Surrozen banks $50M round to fuel its drive to the clinic with regenerative med platform

7 years ago

Biotech C4 raids NIBR for new CMO; EU regulators greenlight Hemlibra expanded label

7 years ago

Bristol-Myers dodges a bullet as PTAB turns down inter partes review pitch for Celgene's cash cow

7 years ago

Merck notches fourth lung cancer approval in Europe for flagship Keytruda

7 years ago

J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs

7 years ago

Deerfield takes translational partnership model to Harvard with $100M deal

7 years ago

CEO of biotech investor Hercules Capital abandons his post in the midst of a college cheating scandal

7 years ago

Scandal-prone Subsys maker Insys falls as auditor flags going concern doubt

7 years ago

First page Previous page 951 952 953954955 956 957 Next page Last page